SB

Surabhi Bhawsar

Active Director Director DIN 09582669
DIN 09582669 First appointment Apr 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2022
Shareholding value •••• Premium profile

About Surabhi Bhawsar

Data last updated:

Surabhi Bhawsar is a Director at Medarth Biotech Private Limited (since 2022). The company operates in Pharma. Medarth Biotech Private Limited reported revenue of ₹61.2 Lakh (FY 2025).

DIN 09582669
Primary Designation Director
Industry Pharma
First Appointment 23 Apr 2022
Oldest Company Age 4 yrs
Largest company Medarth Biotech Private Limited · ₹61.2 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medarth Biotech Private Limited U24299MH2022PTC381210
Director23 Apr 20222022₹61.2 Lakh (FY 2025)Active

Board colleagues of Surabhi Bhawsar

NameDINCompanyDesignation
Siddharth Pawar09582668Medarth Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medarth Biotech Private Limited
Premium access

Shareholding and investment profile for Surabhi Bhawsar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Surabhi Bhawsar

Surabhi Bhawsar currently holds 1 directorship: Medarth Biotech Private Limited (Director, since 23 Apr 2022, revenue ₹61.2 Lakh (FY 2025)).

Surabhi Bhawsar was first appointed on 23 Apr 2022 as Director at Medarth Biotech Private Limited.

The current boards of Surabhi Bhawsar's companies include Siddharth Pawar (Medarth Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available